Company intelligence / Profile preview

Corlife

Hannover, Niedersachsen, Germanycorlife.com ↗

Ownership: Private
Development stage: Commercial

Overview

corlife oHG develops and supplies proprietary tissue-engineered matrix composite devices for use in cardiovascular and cardiothoracic surgeries. Their products are designed to integrate with the patient’s own tissues, becoming indistinguishable from native tissue. The company holds several international patents related to these technologies. Clinical results emphasize improved quality of life post-surgery due to better biocompatibility and integration.

Therapeutic areas: Cardiovascular
Modalities: Tissue-engineered matrix composites
Industry: Implantable Medical Devices

Partnerships

Lifeward partnership to expand access to exoskeleton technology via the CorLife network in the US workers’ compensation market

Beyond the preview

Go deeper on Corlife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corlife.

Explore the full profile